<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/css/bootstrap.min.css" integrity="sha384-B0vP5xmATw1+K9KRQjQERJvTumQW0nPEzvF6L/Z6nronJ3oUOFUFpCjEUQouq2+l" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.15.3/css/all.css" integrity="sha384-SZXxX4whJ79/gErwcOYf+zWLeJdY/qpuqC4cAa9rOGUstPomtqpuNWT9wdPEn2fk" crossorigin="anonymous">
    <link rel="stylesheet" href="css/index.css">
    <link href="https://fonts.googleapis.com/css2?family=Gothic+A1:wght@300;400;500;600&display=swap" rel="stylesheet"> 
    <title>Document</title>
</head>
<body>

<!------------------------ NavigationBar --------------------------->
        
        <!-- <div class="d-none  d-lg-block"> -->
        <div class="container-fluid top-nav">

<nav class="navbar navbar-expand-lg navbar-light bg-light">
  <!-- <a class="navbar-brand" href="#"><img src="image/logo.png" alt="" style="height: 100%;
    width: 150px;"></a> -->
  <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
    <span class="navbar-toggler-icon"></span>
  </button>
  <div class="collapse navbar-collapse" id="navbarNav">
    <ul class="navbar-nav nav-menus">
      <li class="nav-item">
        <a class="nav-link" href="#">STUDY DESIGN</span></a>
      </li>
      <li class="nav-item">
        <a class="nav-link" href="#"  data-toggle="modal" data-target="#exampleModal">REFERENCES</a>
      </li>
      <li class="nav-item">
        <a class="nav-link" href="#">IMPORTANT SAFETY IMPORMATION</a>
      </li>

    </ul>
  </div>
</nav>



</div>
<!-- </div> -->



<!-- Modal -->
<div class="modal fade" id="exampleModal" tabindex="-1" aria-labelledby="exampleModalLabel" aria-hidden="true">
  <div class="modal-dialog modal-xl" style="padding-top:150px;">
    <div class="modal-content" style="border-radius:2rem;">
      <div class="modal-header mod-head">
        <h5 class="modal-title mod-title" id="exampleModalLabel">REFERENCES</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true" style="color:white;">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <ul style="list-style-type:none;padding: 0 0 0 20px; margin: 0;">
          <li class="p-3">
              <p class="mb-0" style="color: #435464;">1. Liu L. lu, J, Allan BW, et al. Generation and characterizarion of xekizumab, a humanized monoclonal antibody that neutralizes <br> interluekin-17A, J Inflamm Res. 2016;9:39-9.</p>
          </li>
          <li class="p-3">
          <p class="mb-0" style="color: #435464;">2.Ixekizumab (Taltz &#174;) Philippines Product Information, July 2019; BR 1299.</p>
          </li>
        </ul>
      </div>
    </div>
  </div>
</div>


<!------------------------ Header --------------------------->
<div class="container">

<div class="jumbotron p-0" style="background-color: transparent;">
<div class="row">
    
    <div class="col-sm-12 col-md-7 col-lg-7" style="padding-top:5rem;">
    <h1 class="display-4 logo"><img src="image/logo.png" alt="" style="height:100px;"></h1>
      <p class="lead mb-0"><strong style="color:green;">XEKIZUMAB (TALITZ)  </strong>  - A TARGET IL-17 A INHIBITOR WITH HIGH BINDING FAMILY</p>
        <p class="com">COMPLETELY <br> CLEAR SKIN</p>
      <!-- <p class="lead mb-0"><a href="#" class="text-white font-weight-bold">Continue reading...</a></p> -->
    </div>
    
    <div class="col-sm-6 col-md-5 offset-md-2 col-lg-5 offset-lg-0">
    <img class="hands" src="image/hand.png" alt="">
    </div>

    <div class="col-sm-12">
    <p class="mb-0 pt-0 desk">IXEKIZUMAB (TALITZ) is the indicated for a treatment of moderate to severe plaque psoriasis in adults who are candidates for systematic theraphy .2 IXEKIZUMAB (TALITZ), alone or in combination with methotrexate, is indicated for the treatment of active psoriasis arthritisin adult patiets who have responded inadiquetly to, or who are intolerant to one or more disease modifying anti-rhuematic drug (DMARD) therapist (see section 6.1)2.</p>   
    </div>  

  </div>
</div>
</div>


<div class="container-fluid mb-5">
  <div class="row">
    <div class="col-sm-6" ><p class="inter">IL-interluekin</p></div>
    <div class="col-sm-6" style="padding-left: 30rem;"><img src="image/lilys.png" alt="" style="width:50%;"> <br> <p style="font-size: 1rem;font-weight: 600;color: #435464;">PH-ELI-TAL-OTH-HCP-0576-V1</p></div>
  </div>
</div>





<script src="https://code.jquery.com/jquery-3.5.1.slim.min.js" integrity="sha384-DfXdz2htPH0lsSSs5nCTpuj/zy4C+OGpamoFVy38MVBnE+IbbVYUew+OrCXaRkfj" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/popper.js@1.16.1/dist/umd/popper.min.js" integrity="sha384-9/reFTGAW83EW2RDu2S0VKaIzap3H66lZH81PoYlFhbGU+6BZp6G7niu735Sk7lN" crossorigin="anonymous"></script>
<script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/js/bootstrap.min.js" integrity="sha384-+YQ4JLhjyBLPDQt//I+STsc9iw4uQqACwlvpslubQzn4u2UU2UFM80nGisd026JF" crossorigin="anonymous"></script>
</body>

</html>